Method for inhibition of rotavirus infection with carrageenan
US5658893A · kind A · utility
2Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 1995 |
| Grant date | Aug 19, 1997 |
| Priority date | — |
| Expiry date | Mar 29, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/731
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for inhibiting rotavirus infection of human cells by treating the rotavirus with a carrageenan. The most effective agent in inhibiting cellular rotavirus infection is lambda-carrageenan, which may be formulated in a liquid and ingested enterally. A composition containing lambda-carrageenan is an aspect of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.